1. Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
2. Weill Department of Medicine, Weill Cornell Medical College, New York, NY;
3. David Geffen School of Medicine at UCLA, Los Angeles, CA;
4. Hemato-oncology Department, Assistance Publique–Hôpitaux de Paris, Hôpital Saint-Louis, Paris Diderot University, Sorbonne Paris-Cité, Paris, France;
5. Winship Cancer Institute of Emory University, Atlanta, GA;
6. Hematologie, Centre Hospitalier Universitaire, Université de Lille, Lille, France;
7. Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;
8. Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL;
9. Clinical Research Alliance, Center for Lymphoma and Myeloma, Weill Cornell Medical College, New York, NY;
10. Florida Cancer Specialists, Atlantis, FL;
11. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA;
12. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
13. Division of Hematology and Medical Oncology, Department of Medicine, Hofstra Northwell School of Medicine, Hempstead, NY;
14. Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; and
15. City of Hope National Medical Center, Duarte, CA